
Biosimilars Regulatory Roundup: May 2025
The FDA’s recent approvals and interchangeability designations for multiple biosimilars mark significant strides in expanding affordable treatment options for complex diseases, even as US drug pricing and global regulatory challenges underscore the urgent …